386 related articles for article (PubMed ID: 31616255)
1. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.
Deák F; Anderson RE; Fessler JL; Sherry DM
Front Cell Neurosci; 2019; 13():428. PubMed ID: 31616255
[TBL] [Abstract][Full Text] [Related]
2. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
3. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
[TBL] [Abstract][Full Text] [Related]
4. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
[TBL] [Abstract][Full Text] [Related]
5. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
Hopiavuori BR; Anderson RE; Agbaga MP
Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
[TBL] [Abstract][Full Text] [Related]
6. Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4.
Yeboah GK; Lobanova ES; Brush RS; Agbaga MP
J Lipid Res; 2021; 62():100030. PubMed ID: 33556440
[TBL] [Abstract][Full Text] [Related]
7. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
[TBL] [Abstract][Full Text] [Related]
8. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
9. The Spinocerebellar Ataxia 34-Causing W246G ELOVL4 Mutation Does Not Alter Cerebellar Neuron Populations in a Rat Model.
Fessler JL; Stiles MA; Agbaga MP; Ahmad M; Sherry DM
Cerebellum; 2024 Jun; ():. PubMed ID: 38850484
[TBL] [Abstract][Full Text] [Related]
10. Synapse-Specific Defects in Synaptic Transmission in the Cerebellum of W246G Mutant ELOVL4 Rats-a Model of Human SCA34.
Nagaraja RY; Stiles MA; Sherry DM; Agbaga MP; Ahmad M
J Neurosci; 2023 Aug; 43(33):5963-5974. PubMed ID: 37491316
[TBL] [Abstract][Full Text] [Related]
11. W246G Mutant ELOVL4 Impairs Synaptic Plasticity in Parallel and Climbing Fibers and Causes Motor Defects in a Rat Model of SCA34.
Nagaraja RY; Sherry DM; Fessler JL; Stiles MA; Li F; Multani K; Orock A; Ahmad M; Brush RS; Anderson RE; Agbaga MP; Deák F
Mol Neurobiol; 2021 Oct; 58(10):4921-4943. PubMed ID: 34227061
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
13. Distribution of ELOVL4 in the Developing and Adult Mouse Brain.
Sherry DM; Hopiavuori BR; Stiles MA; Rahman NS; Ozan KG; Deak F; Agbaga MP; Anderson RE
Front Neuroanat; 2017; 11():38. PubMed ID: 28507511
[TBL] [Abstract][Full Text] [Related]
14. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
[TBL] [Abstract][Full Text] [Related]
15. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
16. Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.
Agbaga MP
Adv Exp Med Biol; 2016; 854():129-35. PubMed ID: 26427403
[TBL] [Abstract][Full Text] [Related]
17. In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.
Mandal NA; Tran JT; Zheng L; Wilkerson JL; Brush RS; McRae J; Agbaga MP; Zhang K; Petrukhin K; Ayyagari R; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2705-13. PubMed ID: 24644051
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of phosphatidylcholines containing very-long-chain polyunsaturated fatty acid in bovine and human retina using liquid chromatography/tandem mass spectrometry.
Berdeaux O; Juaneda P; Martine L; Cabaret S; Bretillon L; Acar N
J Chromatogr A; 2010 Dec; 1217(49):7738-48. PubMed ID: 21035124
[TBL] [Abstract][Full Text] [Related]
19. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
20. Examination of VLC-PUFA-deficient photoreceptor terminals.
Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]